Arlan Biotech uses AI for personalized medicine in a $200B pharma market. The company is pitching deals ranging from $15,000 validation contracts to multi-million dollar pharma partnerships, with some contracts potentially reaching $100M+.
So I think specifically, how many $3 million contracts have you closed and they deposited $9 million? Like you said, you had 3 clients. 3 clients closed.
The 3 clients are B2C clients. They're not B2B clients. And what's the billing for that?
How much did you charge the B2C clients?
So for the B2C clients, we at least charged $15,000. Most of those B2C was for the validation. The growth of the revenue is not like You know, like it's very high. Basically, the market is huge. It's $200 billion market. Of course, we have a competition. We've received results just recently, and we are ahead of the big names.
So how long until you actually book a contract for a $3 million deal? How close is the technology being able to go to one of the big pharma guys and saying, "Hey, we want you to use this"?
You have $0 today, but tomorrow you can get several hundred— several, I mean, tens— tens— I mean, contracts like $10 million, $15 million, $20 million, $100 million contracts. It mostly depends how the deals are done within the firm.
It's a $15,000 deal.
It's not $15,000, it's several hundred thousand US dollars because they're gonna use that for many of targets. If we charge them $30,000 US dollars, And they give the results to their customers within a week, not 12 months. Imagine how many clients they could work. Not 300, but thousands.
